Daxor Corporation (DXR)
USD 8.2
(-0.97%)
USD 8.2
(-0.97%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.28 Million USD | 2910.48% |
| 2022 | 1.13 Million USD | 5.51% |
| 2021 | 1.07 Million USD | 46.11% |
| 2020 | 734.37 Thousand USD | 92.9% |
| 2019 | 380.7 Thousand USD | 26.95% |
| 2018 | 299.87 Thousand USD | 47.22% |
| 2017 | 203.68 Thousand USD | -44.64% |
| 2016 | 367.95 Thousand USD | -15.77% |
| 2015 | 436.82 Thousand USD | -3.62% |
| 2014 | 453.23 Thousand USD | 7.19% |
| 2013 | 422.84 Thousand USD | -27.47% |
| 2012 | 582.98 Thousand USD | -95.5% |
| 2011 | 12.95 Million USD | 272.74% |
| 2010 | -7.49 Million USD | -21.57% |
| 2009 | -6.16 Million USD | 67.34% |
| 2008 | -18.88 Million USD | -72.17% |
| 2007 | -10.96 Million USD | -990.37% |
| 2006 | 1.23 Million USD | 20.19% |
| 2005 | 1.02 Million USD | 128.73% |
| 2004 | 448.13 Thousand USD | -83.06% |
| 2003 | 2.64 Million USD | 30.41% |
| 2002 | 2.02 Million USD | 471.93% |
| 2001 | -545.32 Thousand USD | -32.25% |
| 2000 | -412.32 Thousand USD | -73.75% |
| 1999 | -237.31 Thousand USD | 60.45% |
| 1998 | -600 Thousand USD | 14.29% |
| 1997 | -700 Thousand USD | -131.82% |
| 1996 | 2.2 Million USD | -12.0% |
| 1995 | 2.5 Million USD | 47.06% |
| 1994 | 1.7 Million USD | 30.77% |
| 1993 | 1.3 Million USD | 18.18% |
| 1992 | 1.1 Million USD | -74.42% |
| 1991 | 4.3 Million USD | 960.0% |
| 1990 | -500 Thousand USD | -141.67% |
| 1989 | 1.2 Million USD | 233.33% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 184.65 Thousand USD | 0.0% |
| 2024 Q1 | 184.65 Thousand USD | -88.6% |
| 2023 Q3 | 1.62 Million USD | 5.41% |
| 2023 Q1 | 1.53 Million USD | -55.71% |
| 2023 FY | 34.08 Million USD | 2910.48% |
| 2023 Q4 | 1.62 Million USD | 0.0% |
| 2023 Q2 | 1.53 Million USD | 0.0% |
| 2022 Q4 | 3.46 Million USD | 0.0% |
| 2022 Q3 | 3.46 Million USD | 261.33% |
| 2022 Q1 | 960.27 Thousand USD | -68.82% |
| 2022 FY | 1.13 Million USD | 5.51% |
| 2022 Q2 | 960.27 Thousand USD | 0.0% |
| 2021 Q3 | 3.07 Million USD | 268.93% |
| 2021 Q2 | 834.75 Thousand USD | 0.0% |
| 2021 FY | 1.07 Million USD | 46.11% |
| 2021 Q4 | 3.07 Million USD | 0.0% |
| 2021 Q1 | 834.75 Thousand USD | -0.21% |
| 2020 Q1 | 1.82 Million USD | 246.3% |
| 2020 Q2 | 1.82 Million USD | 0.0% |
| 2020 FY | 734.37 Thousand USD | 92.9% |
| 2020 Q3 | 836.48 Thousand USD | -54.29% |
| 2020 Q4 | 836.48 Thousand USD | 0.0% |
| 2019 Q3 | 528.39 Thousand USD | 157.63% |
| 2019 FY | 380.7 Thousand USD | 26.95% |
| 2019 Q1 | 162.21 Thousand USD | -9.76% |
| 2019 Q2 | -916.8 Thousand USD | -665.17% |
| 2019 Q4 | 528.39 Thousand USD | 0.0% |
| 2018 Q1 | 583.76 Thousand USD | 37.23% |
| 2018 Q3 | 179.75 Thousand USD | -69.21% |
| 2018 Q4 | 179.75 Thousand USD | 0.0% |
| 2018 FY | 299.87 Thousand USD | 47.22% |
| 2018 Q2 | 583.76 Thousand USD | 0.0% |
| 2017 Q3 | 425.39 Thousand USD | 0.93% |
| 2017 Q4 | 425.39 Thousand USD | 0.0% |
| 2017 FY | 203.68 Thousand USD | -44.64% |
| 2017 Q1 | 421.47 Thousand USD | 89.81% |
| 2017 Q2 | 421.47 Thousand USD | 0.0% |
| 2016 Q2 | 707.58 Thousand USD | 0.0% |
| 2016 FY | 367.95 Thousand USD | -15.77% |
| 2016 Q4 | 222.04 Thousand USD | 0.0% |
| 2016 Q3 | 222.04 Thousand USD | -68.62% |
| 2016 Q1 | 707.58 Thousand USD | -65.36% |
| 2015 FY | 436.82 Thousand USD | -3.62% |
| 2015 Q3 | 2.04 Million USD | -12.76% |
| 2015 Q4 | 2.04 Million USD | 0.0% |
| 2015 Q2 | 2.34 Million USD | 0.0% |
| 2015 Q1 | 2.34 Million USD | 94.45% |
| 2014 Q2 | 1.73 Million USD | 0.0% |
| 2014 FY | 453.23 Thousand USD | 7.19% |
| 2014 Q1 | 1.73 Million USD | -46.72% |
| 2014 Q4 | 1.2 Million USD | 0.0% |
| 2014 Q3 | 1.2 Million USD | -30.72% |
| 2013 Q4 | 3.26 Million USD | 0.0% |
| 2013 Q1 | 3.64 Million USD | 1254.1% |
| 2013 FY | 422.84 Thousand USD | -27.47% |
| 2013 Q3 | 3.26 Million USD | -10.6% |
| 2013 Q2 | 3.64 Million USD | 0.0% |
| 2012 FY | 582.98 Thousand USD | -95.5% |
| 2012 Q4 | 269.49 Thousand USD | 0.0% |
| 2012 Q3 | 269.49 Thousand USD | 0.0% |
| 2011 Q1 | 2.59 Million USD | -57.04% |
| 2011 Q3 | 7.19 Million USD | 1388.72% |
| 2011 Q4 | 2.71 Million USD | -62.29% |
| 2011 FY | 12.95 Million USD | 272.74% |
| 2011 Q2 | 483 Thousand USD | -81.41% |
| 2010 FY | -7.49 Million USD | -21.57% |
| 2010 Q4 | 6.04 Million USD | 246.21% |
| 2010 Q3 | -4.13 Million USD | -7688.15% |
| 2010 Q2 | 54.51 Thousand USD | 118.98% |
| 2010 Q1 | -287.17 Thousand USD | -127.57% |
| 2009 Q4 | 1.04 Million USD | 142.0% |
| 2009 FY | -6.16 Million USD | 67.34% |
| 2009 Q1 | 1.7 Million USD | 196.74% |
| 2009 Q2 | -6.44 Million USD | -479.19% |
| 2009 Q3 | -2.48 Million USD | 61.53% |
| 2008 Q1 | -7.08 Million USD | 55.33% |
| 2008 Q3 | -8.5 Million USD | -453.05% |
| 2008 Q4 | -1.75 Million USD | 79.34% |
| 2008 FY | -18.88 Million USD | -72.17% |
| 2008 Q2 | -1.53 Million USD | 78.28% |
| 2007 Q2 | 1.63 Million USD | 158.63% |
| 2007 FY | -10.96 Million USD | -990.37% |
| 2007 Q3 | 1.69 Million USD | 3.91% |
| 2007 Q1 | -2.78 Million USD | -55350.49% |
| 2007 Q4 | -15.85 Million USD | -1035.05% |
| 2006 Q1 | -41.13 Thousand USD | -103.55% |
| 2006 Q4 | -5019.00 USD | -100.45% |
| 2006 Q3 | 1.11 Million USD | -34.57% |
| 2006 Q2 | 1.7 Million USD | 4240.87% |
| 2006 FY | 1.23 Million USD | 20.19% |
| 2005 Q1 | 141.82 Thousand USD | 107.34% |
| 2005 Q2 | 924.24 Thousand USD | 551.7% |
| 2005 Q3 | -1.2 Million USD | -229.97% |
| 2005 Q4 | 1.16 Million USD | 196.58% |
| 2005 FY | 1.02 Million USD | 128.73% |
| 2004 Q2 | 171.36 Thousand USD | 2231.41% |
| 2004 Q3 | 842.58 Thousand USD | 391.69% |
| 2004 Q4 | -1.93 Million USD | -329.27% |
| 2004 FY | 448.13 Thousand USD | -83.06% |
| 2004 Q1 | -8040.00 USD | -101.07% |
| 2003 Q4 | 752.97 Thousand USD | 26.2% |
| 2003 FY | 2.64 Million USD | 30.41% |
| 2003 Q3 | 596.63 Thousand USD | -9.11% |
| 2003 Q1 | 653.39 Thousand USD | 0.49% |
| 2003 Q2 | 656.46 Thousand USD | 0.47% |
| 2002 Q1 | 410.77 Thousand USD | 361.78% |
| 2002 Q4 | 650.17 Thousand USD | 27.42% |
| 2002 Q2 | 468.57 Thousand USD | 14.07% |
| 2002 FY | 2.02 Million USD | 471.93% |
| 2002 Q3 | 510.25 Thousand USD | 8.89% |
| 2001 Q2 | -146.27 Thousand USD | -21.39% |
| 2001 Q1 | -120.49 Thousand USD | -279.82% |
| 2001 FY | -545.32 Thousand USD | -32.25% |
| 2001 Q4 | -156.91 Thousand USD | -42.5% |
| 2001 Q3 | -110.11 Thousand USD | 24.72% |
| 2000 FY | -412.32 Thousand USD | -73.75% |
| 2000 Q2 | -144.26 Thousand USD | -49.19% |
| 2000 Q1 | -96.69 Thousand USD | -120.9% |
| 2000 Q3 | -264.16 Thousand USD | -83.11% |
| 2000 Q4 | 67.01 Thousand USD | 125.37% |
| 1999 Q1 | -600 Thousand USD | -200.0% |
| 1999 FY | -237.31 Thousand USD | 60.45% |
| 1999 Q4 | 462.68 Thousand USD | 562.69% |
| 1999 Q3 | -100 Thousand USD | 50.0% |
| 1999 Q2 | -200 Thousand USD | 66.67% |
| 1998 Q4 | -200 Thousand USD | 0.0% |
| 1998 Q2 | -400 Thousand USD | -33.33% |
| 1998 FY | -600 Thousand USD | 14.29% |
| 1998 Q3 | -200 Thousand USD | 50.0% |
| 1998 Q1 | -300 Thousand USD | -125.0% |
| 1997 Q2 | -100 Thousand USD | 66.67% |
| 1997 Q1 | -300 Thousand USD | -150.0% |
| 1997 FY | -700 Thousand USD | -131.82% |
| 1997 Q4 | 1.2 Million USD | 250.0% |
| 1997 Q3 | -800 Thousand USD | -700.0% |
| 1996 Q3 | 500 Thousand USD | 0.0% |
| 1996 Q2 | 500 Thousand USD | -16.67% |
| 1996 Q1 | 600 Thousand USD | -45.45% |
| 1996 FY | 2.2 Million USD | -12.0% |
| 1996 Q4 | 600 Thousand USD | 20.0% |
| 1995 FY | 2.5 Million USD | 47.06% |
| 1995 Q3 | 600 Thousand USD | 50.0% |
| 1995 Q2 | 400 Thousand USD | 33.33% |
| 1995 Q1 | 300 Thousand USD | -57.14% |
| 1995 Q4 | 1.1 Million USD | 83.33% |
| 1994 FY | 1.7 Million USD | 30.77% |
| 1994 Q4 | 700 Thousand USD | 133.33% |
| 1994 Q3 | 300 Thousand USD | 0.0% |
| 1994 Q2 | 300 Thousand USD | 0.0% |
| 1994 Q1 | 300 Thousand USD | -25.0% |
| 1993 Q2 | 300 Thousand USD | -50.0% |
| 1993 Q4 | 400 Thousand USD | 33.33% |
| 1993 Q1 | 600 Thousand USD | 50.0% |
| 1993 Q3 | 300 Thousand USD | 0.0% |
| 1993 FY | 1.3 Million USD | 18.18% |
| 1992 FY | 1.1 Million USD | -74.42% |
| 1992 Q4 | 400 Thousand USD | 100.0% |
| 1992 Q3 | 200 Thousand USD | 0.0% |
| 1992 Q2 | 200 Thousand USD | -33.33% |
| 1992 Q1 | 300 Thousand USD | 200.0% |
| 1991 Q3 | 200 Thousand USD | 166.67% |
| 1991 Q4 | 100 Thousand USD | -50.0% |
| 1991 Q1 | 3.8 Million USD | 1800.0% |
| 1991 Q2 | -300 Thousand USD | -107.89% |
| 1991 FY | 4.3 Million USD | 960.0% |
| 1990 FY | -500 Thousand USD | -141.67% |
| 1990 Q3 | -100 Thousand USD | 50.0% |
| 1990 Q2 | -200 Thousand USD | 50.0% |
| 1990 Q1 | -400 Thousand USD | 0.0% |
| 1990 Q4 | 200 Thousand USD | 300.0% |
| 1989 FY | 1.2 Million USD | 233.33% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 98.772% |
| AngioDynamics, Inc. | 252.41 Million USD | 99.493% |
| AtriCure, Inc. | 327.05 Million USD | 99.608% |
| Avinger, Inc. | 18.63 Million USD | 93.13% |
| Azenta, Inc. | 336.26 Million USD | 99.619% |
| BioLife Solutions, Inc. | 117.57 Million USD | 98.911% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.93% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 94.707% |
| Femasys Inc. | 15.2 Million USD | 91.576% |
| GlucoTrack, Inc. | 7.1 Million USD | 81.975% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 97.814% |
| Hologic, Inc. | 1.34 Billion USD | 99.905% |
| ICU Medical, Inc. | 717.04 Million USD | 99.821% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.957% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 95.095% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 98.583% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1173.096% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1173.096% |
| Masimo Corporation | 867 Million USD | 99.852% |
| Microbot Medical Inc. | 9.85 Million USD | 87.006% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 93.048% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 99.722% |
| Nephros, Inc. | 9.78 Million USD | 86.912% |
| NovoCure Limited | 613.92 Million USD | 99.791% |
| NEXGEL, Inc. | 4.09 Million USD | 68.737% |
| NEXGEL, Inc. | 4.09 Million USD | 68.737% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 98.748% |
| OraSure Technologies, Inc. | 125.34 Million USD | 98.978% |
| Pro-Dex, Inc. | 7.37 Million USD | 82.644% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 97.061% |
| Predictive Oncology Inc. | 15.22 Million USD | 91.592% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | 84.974% |
| QuidelOrtho Corporation | 1.35 Billion USD | 99.906% |
| Repligen Corporation | 261.12 Million USD | 99.51% |
| Sanara MedTech Inc. | 61.12 Million USD | 97.905% |
| STAAR Surgical Company | 224.55 Million USD | 99.43% |
| Sharps Technology, Inc. | 10.12 Million USD | 87.355% |
| Utah Medical Products, Inc. | 13.26 Million USD | 90.344% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.929% |
| Jin Medical International Ltd. | 3.91 Million USD | 67.314% |